Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Oral somatosensatory acuity is related to particle size perception in chocolate.

Breen SP, Etter NM, Ziegler GR, Hayes JE.

Sci Rep. 2019 May 15;9(1):7437. doi: 10.1038/s41598-019-43944-7.

2.

Relationship between parent mood and resilience and child health outcomes in pediatric asthma.

Tully C, Rose M, Breen S, Herrera N, Shelef DQ, Streisand R, Teach SJ.

Fam Syst Health. 2019 Jun;37(2):167-172. doi: 10.1037/fsh0000417. Epub 2019 May 6.

PMID:
31058528
3.

Are changes in running economy associated with changes in performance in runners? A systematic review and meta-analysis.

O Sullivan IJ, Johnson MI, Hind K, Breen S, Francis P.

J Sports Sci. 2019 Jul;37(13):1521-1533. doi: 10.1080/02640414.2019.1575177. Epub 2019 Feb 27.

PMID:
30810467
4.

AVR2 Targets BSL Family Members, Which Act as Susceptibility Factors to Suppress Host Immunity.

Turnbull D, Wang H, Breen S, Malec M, Naqvi S, Yang L, Welsh L, Hemsley P, Zhendong T, Brunner F, Gilroy EM, Birch PRJ.

Plant Physiol. 2019 May;180(1):571-581. doi: 10.1104/pp.18.01143. Epub 2019 Feb 19.

PMID:
30782963
5.

Improved Therapeutic Window in BRCA-mutant Tumors with Antibody-linked Pyrrolobenzodiazepine Dimers with and without PARP Inhibition.

Zhong H, Chen C, Tammali R, Breen S, Zhang J, Fazenbaker C, Kennedy M, Conway J, Higgs BW, Holoweckyj N, Raja R, Harper J, Pierce AJ, Herbst R, Tice DA.

Mol Cancer Ther. 2019 Jan;18(1):89-99. doi: 10.1158/1535-7163.MCT-18-0314. Epub 2018 Oct 23.

PMID:
30352801
6.

Preclinical assessment of an antibody-PBD conjugate that targets BCMA on multiple myeloma and myeloma progenitor cells.

Kinneer K, Flynn M, Thomas SB, Meekin J, Varkey R, Xiao X, Zhong H, Breen S, Hynes PG, Fleming R, Bezabeh B, Chen CT, Wetzel L, Chen R, Dimasi N, Tai YT, Anderson KC, Herbst R, Howard PW, Hurt EM, Tice DA.

Leukemia. 2019 Mar;33(3):766-771. doi: 10.1038/s41375-018-0278-7. Epub 2018 Oct 12. No abstract available.

PMID:
30315237
7.

Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer.

Bosco EE, Christie RJ, Carrasco R, Sabol D, Zha J, DaCosta K, Brown L, Kennedy M, Meekin J, Phipps S, Ayriss J, Du Q, Bezabeh B, Chowdhury P, Breen S, Chen C, Reed M, Hinrichs M, Zhong H, Xiao Z, Dixit R, Herbst R, Tice DA.

Oncotarget. 2018 May 1;9(33):22960-22975. doi: 10.18632/oncotarget.25160. eCollection 2018 May 1.

8.

Barriers to implementing the Sepsis Six guidelines in an acute hospital setting.

Breen SJ, Rees S.

Br J Nurs. 2018 May 10;27(9):473-478. doi: 10.12968/bjon.2018.27.9.473.

PMID:
29749778
9.

Image registration assessment in radiotherapy image guidance based on control chart monitoring.

Xia W, Breen SL.

J Med Imaging (Bellingham). 2018 Apr;5(2):021221. doi: 10.1117/1.JMI.5.2.021221. Epub 2018 Mar 14.

10.

Considering Culture: A Review of Pediatric Behavioral Intervention Research in Type 1 Diabetes.

Rose M, Aronow L, Breen S, Tully C, Hilliard ME, Butler AM, Streisand R.

Curr Diab Rep. 2018 Feb 23;18(4):16. doi: 10.1007/s11892-018-0987-3. Review.

PMID:
29473103
11.

Loss of AvrSr50 by somatic exchange in stem rust leads to virulence for Sr50 resistance in wheat.

Chen J, Upadhyaya NM, Ortiz D, Sperschneider J, Li F, Bouton C, Breen S, Dong C, Xu B, Zhang X, Mago R, Newell K, Xia X, Bernoux M, Taylor JM, Steffenson B, Jin Y, Zhang P, Kanyuka K, Figueroa M, Ellis JG, Park RF, Dodds PN.

Science. 2017 Dec 22;358(6370):1607-1610. doi: 10.1126/science.aao4810.

PMID:
29269475
12.

Mobile Health Intervention to Increase Oral Cancer Therapy Adherence in Patients With Chronic Myeloid Leukemia (The REMIND System): Clinical Feasibility and Acceptability Assessment.

Pereira-Salgado A, Westwood JA, Russell L, Ugalde A, Ortlepp B, Seymour JF, Butow P, Cavedon L, Ong K, Aranda S, Breen S, Kirsa S, Dunlevie A, Schofield P.

JMIR Mhealth Uhealth. 2017 Dec 6;5(12):e184. doi: 10.2196/mhealth.8349.

13.

The experiences of patients with advanced cancer and caregivers presenting to Emergency Departments: A qualitative study.

Philip J, Remedios C, Breen S, Weiland T, Willenberg L, Boughey M, Jelinek G, Lane H, Marck C, Weil J.

Palliat Med. 2018 Feb;32(2):439-446. doi: 10.1177/0269216317735724. Epub 2017 Nov 13.

PMID:
29130378
14.

Brachytherapy patient safety events in an academic radiation medicine program.

Felder S, Morley L, Ng E, Chan K, Ballantyne H, Di Tomasso A, Borg J, Bissonnette JP, Breen S, Waldron J, Rink A, Milosevic M.

Brachytherapy. 2018 Jan - Feb;17(1):16-23. doi: 10.1016/j.brachy.2017.06.010. Epub 2017 Jul 27.

PMID:
28757402
15.

Emerging Insights into the Functions of Pathogenesis-Related Protein 1.

Breen S, Williams SJ, Outram M, Kobe B, Solomon PS.

Trends Plant Sci. 2017 Oct;22(10):871-879. doi: 10.1016/j.tplants.2017.06.013. Epub 2017 Jul 22. Review.

PMID:
28743380
16.

Fractionated Dosing Improves Preclinical Therapeutic Index of Pyrrolobenzodiazepine-Containing Antibody Drug Conjugates.

Hinrichs MJM, Ryan PM, Zheng B, Afif-Rider S, Yu XQ, Gunsior M, Zhong H, Harper J, Bezabeh B, Vashisht K, Rebelatto M, Reed M, Ryan PC, Breen S, Patel N, Chen C, Masterson L, Tiberghien A, Howard PW, Dimasi N, Dixit R.

Clin Cancer Res. 2017 Oct 1;23(19):5858-5868. doi: 10.1158/1078-0432.CCR-17-0219. Epub 2017 Jun 19.

17.

Preclinical Evaluation of MEDI0641, a Pyrrolobenzodiazepine-Conjugated Antibody-Drug Conjugate Targeting 5T4.

Harper J, Lloyd C, Dimasi N, Toader D, Marwood R, Lewis L, Bannister D, Jovanovic J, Fleming R, D'Hooge F, Mao S, Marrero AM, Korade M 3rd, Strout P, Xu L, Chen C, Wetzel L, Breen S, van Vlerken-Ysla L, Jalla S, Rebelatto M, Zhong H, Hurt EM, Hinrichs MJ, Huang K, Howard PW, Tice DA, Hollingsworth RE, Herbst R, Kamal A.

Mol Cancer Ther. 2017 Aug;16(8):1576-1587. doi: 10.1158/1535-7163.MCT-16-0825. Epub 2017 May 18.

18.

Utility values associated with advanced or metastatic non-small cell lung cancer: data needs for economic modeling.

Brown J, Cook K, Adamski K, Lau J, Bargo D, Breen S, Chawla A.

Expert Rev Pharmacoecon Outcomes Res. 2017 Apr;17(2):153-164. doi: 10.1080/14737167.2017.1311210. Review.

PMID:
28335636
19.

RXLR Effector AVR2 Up-Regulates a Brassinosteroid-Responsive bHLH Transcription Factor to Suppress Immunity.

Turnbull D, Yang L, Naqvi S, Breen S, Welsh L, Stephens J, Morris J, Boevink PC, Hedley PE, Zhan J, Birch PRJ, Gilroy EM.

Plant Physiol. 2017 May;174(1):356-369. doi: 10.1104/pp.16.01804. Epub 2017 Mar 7.

20.

Effect of Standard Radiotherapy With Cisplatin vs Accelerated Radiotherapy With Panitumumab in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma: A Randomized Clinical Trial.

Siu LL, Waldron JN, Chen BE, Winquist E, Wright JR, Nabid A, Hay JH, Ringash J, Liu G, Johnson A, Shenouda G, Chasen M, Pearce A, Butler JB, Breen S, Chen EX, FitzGerald TJ, Childs TJ, Montenegro A, O'Sullivan B, Parulekar WR.

JAMA Oncol. 2017 Feb 1;3(2):220-226. doi: 10.1001/jamaoncol.2016.4510.

PMID:
27930762
21.

Wheat PR-1 proteins are targeted by necrotrophic pathogen effector proteins.

Breen S, Williams SJ, Winterberg B, Kobe B, Solomon PS.

Plant J. 2016 Oct;88(1):13-25. doi: 10.1111/tpj.13228. Epub 2016 Aug 10.

22.

Overproduction of IGF-2 drives a subset of colorectal cancer cells, which specifically respond to an anti-IGF therapeutic antibody and combination therapies.

Zhong H, Fazenbaker C, Chen C, Breen S, Huang J, Yao X, Ren P, Yao Y, Herbst R, Hollingsworth RE.

Oncogene. 2017 Feb 9;36(6):797-806. doi: 10.1038/onc.2016.248. Epub 2016 Jul 11.

PMID:
27399333
23.

Differential effector gene expression underpins epistasis in a plant fungal disease.

Phan HT, Rybak K, Furuki E, Breen S, Solomon PS, Oliver RP, Tan KC.

Plant J. 2016 Aug;87(4):343-54. doi: 10.1111/tpj.13203. Epub 2016 Jul 7.

24.

Production of small cysteine-rich effector proteins in Escherichia coli for structural and functional studies.

Zhang X, Nguyen N, Breen S, Outram MA, Dodds PN, Kobe B, Solomon PS, Williams SJ.

Mol Plant Pathol. 2017 Jan;18(1):141-151. doi: 10.1111/mpp.12385. Epub 2016 Apr 12.

PMID:
26915457
25.

A Novel IL6 Antibody Sensitizes Multiple Tumor Types to Chemotherapy Including Trastuzumab-Resistant Tumors.

Zhong H, Davis A, Ouzounova M, Carrasco RA, Chen C, Breen S, Chang YS, Huang J, Liu Z, Yao Y, Hurt E, Moisan J, Fung M, Tice DA, Clouthier SG, Xiao Z, Wicha MS, Korkaya H, Hollingsworth RE.

Cancer Res. 2016 Jan 15;76(2):480-90. doi: 10.1158/0008-5472.CAN-15-0883. Epub 2016 Jan 7.

26.

Surveying the potential of secreted antimicrobial peptides to enhance plant disease resistance.

Breen S, Solomon PS, Bedon F, Vincent D.

Front Plant Sci. 2015 Oct 27;6:900. doi: 10.3389/fpls.2015.00900. eCollection 2015. Review.

27.
28.

Lesbian, Gay, Bisexual, Transgender, Queer/Questioning (LGBTQ) Perceptions and Health Care Experiences.

Quinn GP, Sutton SK, Winfield B, Breen S, Canales J, Shetty G, Sehovic I, Green BL, Schabath MB.

J Gay Lesbian Soc Serv. 2015;27(2):246-261. doi: 10.1080/10538720.2015.1022273. Epub 2015 Jun 10.

29.

MEDI-573, alone or in combination with mammalian target of rapamycin inhibitors, targets the insulin-like growth factor pathway in sarcomas.

Zhong H, Fazenbaker C, Breen S, Chen C, Huang J, Morehouse C, Yao Y, Hollingsworth RE.

Mol Cancer Ther. 2014 Nov;13(11):2662-73. doi: 10.1158/1535-7163.MCT-14-0144. Epub 2014 Sep 5. Erratum in: Mol Cancer Ther. 2015 Mar;14(3):844.

30.

A facility for magnetic resonance-guided radiation therapy.

Jaffray DA, Carlone MC, Milosevic MF, Breen SL, Stanescu T, Rink A, Alasti H, Simeonov A, Sweitzer MC, Winter JD.

Semin Radiat Oncol. 2014 Jul;24(3):193-5. doi: 10.1016/j.semradonc.2014.02.012.

PMID:
24931091
31.

The past, present and future of secondary metabolite research in the Dothideomycetes.

Muria-Gonzalez MJ, Chooi YH, Breen S, Solomon PS.

Mol Plant Pathol. 2015 Jan;16(1):92-107. doi: 10.1111/mpp.12162. Epub 2014 Jul 7. Review.

PMID:
24889519
32.

Effects of altering the dose and timing of triptorelin when given as an intravaginal gel for advancing and synchronizing ovulation in weaned sows.

Knox RV, Taibl JN, Breen SM, Swanson ME, Webel SK.

Theriogenology. 2014 Aug;82(3):379-86. doi: 10.1016/j.theriogenology.2014.04.020. Epub 2014 May 2.

PMID:
24888686
33.

The effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamics.

Devanaboyina SC, Lynch SM, Ober RJ, Ram S, Kim D, Puig-Canto A, Breen S, Kasturirangan S, Fowler S, Peng L, Zhong H, Jermutus L, Wu H, Webster C, Ward ES, Gao C.

MAbs. 2013 Nov-Dec;5(6):851-9. doi: 10.4161/mabs.26389.

34.

Technical challenges of sparing infrahyoid swallowing organs at risk in oropharynx squamous cell cancer treated with IMRT.

Morley L, Tsang SW, Breen SL, Waldron JN, Maganti M, Pintilie M, Dawson LA, Ringash J, Huang SH, Kim J.

Med Dosim. 2014 Summer;39(2):146-51. doi: 10.1016/j.meddos.2013.11.006. Epub 2014 Jan 17.

PMID:
24440166
35.

A Practice-based Taxonomy for Radiation Treatment Errors.

Lam C, Medlam G, Wighton A, Breen SL, Bissonnette JP, McGowan TS, Carlone M, Milosevic MF.

J Med Imaging Radiat Sci. 2013 Dec;44(4):173-179. doi: 10.1016/j.jmir.2013.08.001. Epub 2013 Oct 21.

PMID:
31051925
36.

Ovulation involves the luteinizing hormone-dependent activation of G(q/11) in granulosa cells.

Breen SM, Andric N, Ping T, Xie F, Offermans S, Gossen JA, Ascoli M.

Mol Endocrinol. 2013 Sep;27(9):1483-91. doi: 10.1210/me.2013-1130. Epub 2013 Jul 8.

37.

Cancer patient and clinician acceptability and feasibility of a supportive care screening and referral process.

Ristevski E, Regan M, Jones R, Breen S, Batson A, McGrail MR.

Health Expect. 2015 Jun;18(3):406-18. doi: 10.1111/hex.12045. Epub 2013 Jan 31.

38.

Host protein BSL1 associates with Phytophthora infestans RXLR effector AVR2 and the Solanum demissum Immune receptor R2 to mediate disease resistance.

Saunders DG, Breen S, Win J, Schornack S, Hein I, Bozkurt TO, Champouret N, Vleeshouwers VG, Birch PR, Gilroy EM, Kamoun S.

Plant Cell. 2012 Aug;24(8):3420-34. Epub 2012 Aug 10.

39.

Poster - Thur Eve - 05: Safety systems and failure modes and effects analysis for a magnetic resonance image guided radiation therapy system.

Lamey M, Carlone M, Alasti H, Bissonnette JP, Borg J, Breen S, Coolens C, Heaton R, Islam M, van Proojen M, Sharpe M, Stanescu T, Jaffray D.

Med Phys. 2012 Jul;39(7Part2):4625. doi: 10.1118/1.4740112.

PMID:
28516558
40.

The impact of dose of FSH (Folltropin) containing LH (Lutropin) on follicular development, estrus and ovulation responses in prepubertal gilts.

Breen SM, Knox RV.

Anim Reprod Sci. 2012 Jun;132(3-4):193-200. doi: 10.1016/j.anireprosci.2012.05.013. Epub 2012 May 28.

PMID:
22683028
41.

The Effect of Registration Volume Extent on Residual Errors Assessed Using Cone-Beam Computed Tomography in Radiation Treatment of Head and Neck Cancer.

Morley L, Waldron J, Dawson L, Bayley A, Ringash J, Cummings B, Kim J, O'Sullivan B, Breen SL.

J Med Imaging Radiat Sci. 2012 Jun;43(2):95-102. doi: 10.1016/j.jmir.2012.01.002. Epub 2012 Mar 24.

PMID:
31052032
42.

SU-D-213CD-06: Workflow and Safety Systems of a Linac-MR Sim-Brachytherapy MRgRT™ Facility.

Winter J, Carlone M, Stanescu T, Breen S, Foxcroft S, Guyot B, Dahan M, Dahdal R, Jaffray D.

Med Phys. 2012 Jun;39(6Part3):3618-3619. doi: 10.1118/1.4734691.

PMID:
28517391
43.

Implementation of remote 3-dimensional image guided radiation therapy quality assurance for radiation therapy oncology group clinical trials.

Cui Y, Galvin JM, Parker W, Breen S, Yin FF, Cai J, Papiez LS, Li XA, Bednarz G, Chen W, Xiao Y.

Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):271-7. doi: 10.1016/j.ijrobp.2012.03.002. Epub 2012 Apr 27.

PMID:
22541964
44.

Benefits of remote real-time side-effect monitoring systems for patients receiving cancer treatment.

Kofoed S, Breen S, Gough K, Aranda S.

Oncol Rev. 2012 Jun 5;6(1):e7. doi: 10.4081/oncol.2012.e7. eCollection 2012 Mar 5. Review.

45.

MEDI3617, a human anti-angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models.

Leow CC, Coffman K, Inigo I, Breen S, Czapiga M, Soukharev S, Gingles N, Peterson N, Fazenbaker C, Woods R, Jallal B, Ricketts SA, Lavallee T, Coats S, Chang Y.

Int J Oncol. 2012 May;40(5):1321-30. doi: 10.3892/ijo.2012.1366. Epub 2012 Feb 10.

PMID:
22327175
46.

A national survey of the availability of intensity-modulated radiation therapy and stereotactic radiosurgery in Canada.

AlDuhaiby EZ, Breen S, Bissonnette JP, Sharpe M, Mayhew L, Tyldesley S, Wilke DR, Hodgson DC.

Radiat Oncol. 2012 Feb 7;7:18. doi: 10.1186/1748-717X-7-18.

47.

Practical limitations on astrophysical observations of methanol to investigate variations in the proton-to-electron mass ratio.

Ellingsen S, Voronkov M, Breen S.

Phys Rev Lett. 2011 Dec 30;107(27):270801. Epub 2011 Dec 29.

PMID:
22243297
48.

Improving superficial target delineation in radiation therapy with endoscopic tracking and registration.

Weersink RA, Qiu J, Hope AJ, Daly MJ, Cho BC, Dacosta RS, Sharpe MB, Breen SL, Chan H, Jaffray DA.

Med Phys. 2011 Dec;38(12):6458-68. doi: 10.1118/1.3658569.

PMID:
22149829
49.

Auto-segmentation of normal and target structures in head and neck CT images: a feature-driven model-based approach.

Qazi AA, Pekar V, Kim J, Xie J, Breen SL, Jaffray DA.

Med Phys. 2011 Nov;38(11):6160-70. doi: 10.1118/1.3654160.

PMID:
22047381
50.

Soccer-specific endurance and running economy in soccer players with cerebral palsy.

Kloyiam S, Breen S, Jakeman P, Conway J, Hutzler Y.

Adapt Phys Activ Q. 2011 Oct;28(4):354-67.

PMID:
21914907

Supplemental Content

Support Center